Author

Marc Philipp Schauer

Universitätsklinikum WürzburgORCID 0009-0009-9308-826XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Barbara AltieriiD· 2 shared Martin FaßnachtiD· 2 shared Silviu SbieraiD· 2 shared Cristina Lucia RonchiiD· 1 shared David S. TourignyiD· 1 shared Hermann EinseleiD· 1 shared Justus WeberiD· 1 shared Katja Kiseljak‐VassiliadesiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Barbara AltieriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 28, 2025

Tumour-derived glucocorticoids amplify ROR1 and are exploited with glucocorticoid-resistant ROR1 CAR-T cells

Marc Philipp Schauer, Justus Weber, Peter Spieler…·Michael Hudecek

The paper shows that tumor-derived glucocorticoids increase ROR1 expression while suppressing T cell activity, and GC-resistant CAR-T cells can overcome this by preserving ROR1 expression in tumor cells.

3 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 9, 2023

Cellular landscape of adrenocortical carcinoma at single-nuclei resolution

David S. Tourigny, Barbara Altieri, Kerim Secener…·Cristina Lucia Ronchi

This study uses single-nuclei RNA sequencing to analyze adrenocortical carcinoma and identifies distinct cell populations associated with different tumor aggressiveness and molecular features.

DOI 10.1101/2023.10.09.561514

humansnRNA-seq

𝕏 PostBluesky